0000899243-22-013322.txt : 20220404 0000899243-22-013322.hdr.sgml : 20220404 20220404161531 ACCESSION NUMBER: 0000899243-22-013322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Doebele Robert CENTRAL INDEX KEY: 0001856681 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40356 FILM NUMBER: 22802369 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rain Therapeutics Inc. CENTRAL INDEX KEY: 0001724979 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821130967 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: (510) 953-5559 MAIL ADDRESS: STREET 1: 8000 JARVIS AVENUE STREET 2: SUITE 204 CITY: NEWARK STATE: CA ZIP: 94560 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-31 0 0001724979 Rain Therapeutics Inc. RAIN 0001856681 Doebele Robert C/O RAIN THERAPEUTICS INC. 8000 JARVIS AVENUE, SUITE 204 NEWARK CA 94560 0 1 0 0 See Remarks Common Stock 2022-03-31 4 M 0 2000 3.95 A 469937 D Stock Option (Right to Buy) 3.95 2022-03-31 4 M 0 2000 0.00 D 2029-03-13 Common Stock 2000 11890 D This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full. President, Chief Scientific Officer /s/ Nelson Cabatuan, Attorney-in-fact for Robert Doebele 2022-04-04